Free tool
Stocks near their 52-week high
We cover 71 companies trading within 5% of their own 52-week high. The median market value in the group is $2.02B. Across the group, the median move over the past trading day is 0.00%. 99% of the 68 with a 200-day average trade above it. Price change over the past year runs from +8.1% to +191.3% across the middle 80 percent of the group, with a median of +56.7%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
71 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +62.83% |
| TWST | Twist Bioscience Corporation | $9.41B | Mid cap | +451.89% |
| DEMANT.CO | Demant A/S | $9.36B | Mid cap | +17.12% |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +189.13% |
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +74.18% |
| 6869.T | Sysmex Corporation | $7.28B | Mid cap | +3.66% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% |
| CGON | CG Oncology, Inc. | $6.95B | Mid cap | +196.15% |
| E2XE34.SA | Exelixis, Inc. | $6.61B | Mid cap | +23.92% |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% |
| SHC | Sotera Health Company | $5.58B | Mid cap | +18.42% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.07B | Mid cap | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +93.26% |
| ELVN | Enliven Therapeutics, Inc. | $4.46B | Mid cap | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.08B | Mid cap | +1.26% |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% |
| BBZA.DE | BB Biotech AG | $3.87B | Mid cap | +7.22% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +61.66% |
| PHVS | Pharvaris N.V. | $2.60B | Mid cap | +55.59% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% |
| ADUS | Addus HomeCare Corporation | $2.25B | Mid cap | +4.50% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +28.14% |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.02B | Mid cap | +79.12% |
| VIMIAN.ST | Vimian Group AB (publ) | $1.99B | Small cap | +12.01% |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% |
| PYC.AX | PYC Therapeutics Limited | $1.60B | Small cap | +74.42% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | $1.58B | Small cap | +298.89% |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +100.54% |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% |
| 3148.T | Create SD Holdings Co., Ltd. | $1.38B | Small cap | +1.90% |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +110.53% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | $1.08B | Small cap | +35.66% |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +42.19% |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% |
| B2RK34.SA | Bruker Corporation | $906.52M | Small cap | +63.27% |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +93.73% |
| AMS.L | Advanced Medical Solutions Group plc | $830.96M | Small cap | +38.01% |
| UU8.F | Neurogene Inc. | $795.50M | Small cap | +165.60% |
| 7575.T | Japan Lifeline Co., Ltd. | $694.70M | Small cap | +12.02% |
| GUD.TO | Knight Therapeutics Inc. | $690.78M | Small cap | +50.39% |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% |
| CTNM | Contineum Therapeutics, Inc. | $640.31M | Small cap | +70.03% |
| 6197.T | Solasto Corporation | $635.28M | Small cap | +136.68% |
| EOLS | Evolus, Inc. | $579.92M | Small cap | +15.83% |
| 2664.T | Cawachi Limited | $531.16M | Small cap | +38.25% |
| 7979.T | Shofu Inc. | $517.24M | Small cap | +21.34% |
| 3151.T | Vital KSK Holdings, Inc. | $501.27M | Small cap | +40.44% |
| PBYI | Puma Biotechnology, Inc. | $472.84M | Small cap | +79.61% |
| HNSA.ST | Hansa Biopharma AB (publ) | $450.66M | Small cap | +35.65% |
| FRX.TO | Fennec Pharmaceuticals Inc. | $429.52M | Small cap | +36.00% |
| 5889.T | JAPAN EYEWEAR HOLDINGS CO LTD | $397.43M | Small cap | +27.04% |
| IKT | Inhibikase Therapeutics, Inc. | $347.44M | Small cap | +39.11% |
| LIK.DE | LIMES Schlosskliniken AG | $199.75M | Small cap | +70.66% |
| LOVE.TO | Cannara Biotech Inc. | $141.63M | Small cap | +11.80% |
| 4599.T | StemRIM | $140.21M | Small cap | +14.75% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.